Home - Products - Others - Other Targets - N-(4-bromo-2-chlorophenyl)-5-chloro-2-hydroxybenzamide

N-(4-bromo-2-chlorophenyl)-5-chloro-2-hydroxybenzamide

CAS No. 1098360-68-9

N-(4-bromo-2-chlorophenyl)-5-chloro-2-hydroxybenzamide ( —— )

Catalog No. M28422 CAS No. 1098360-68-9

N-(4-bromo-2-chlorophenyl)-5-chloro-2-hydroxybenzamide is a chemical compound.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
2MG 113 Get Quote
5MG 174 Get Quote
10MG 262 Get Quote
25MG 447 Get Quote
50MG 651 Get Quote
100MG 888 Get Quote
500MG 1782 Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    N-(4-bromo-2-chlorophenyl)-5-chloro-2-hydroxybenzamide
  • Note
    Research use only, not for human use.
  • Brief Description
    N-(4-bromo-2-chlorophenyl)-5-chloro-2-hydroxybenzamide is a chemical compound.
  • Description
    N-(4-bromo-2-chlorophenyl)-5-chloro-2-hydroxybenzamide is a chemical compound.
  • Synonyms
    ——
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    apolipoprotein L1
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    1098360-68-9
  • Formula Weight
    361.0
  • Molecular Formula
    C13H8BrCl2NO2
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    Oc1ccc(Cl)cc1C(=O)Nc1ccc(Br)cc1Cl
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.WO2020131807
molnova catalog
related products
  • L-Methionine-DL-sulf...

    L-Methionine-DL-sulfoximine inhibits glutamine synthetase and metabolically and morphologically primarily affects astroglia. L-Methionine-DL-sulfoximine can be used in convulsant studies.

  • Kobophenol A

    Kobophenol A has antimicrobial, and anti-inflammatory activities, it might be a candidate for treatment of inflammatory bone diseases relevant to osteoblast cell death.

  • N-trans-Sinapoyltyra...

    N-trans-Sinapoyltyramine exhibited strong and selective cytotoxicity on the HeLa human cancer cell line with IC50 values of 9.77 ± 1.25 Μm.